Cannabis sales in January fell 3.1% sequentially, yet rose 4.6% year over year across 15 markets. MyCBDAdvisor breaks down what that means for retailers, investors, and policy watchers. We rely on BDSA and New Cannabis Ventures data to highlight trends and practical insights.

However, the story varies by state. Illinois updated how it counts sales, which changed totals. Ohio began adult use last August and that boost shows. Florida and Pennsylvania remain medical only, so patterns differ there.

As a result, some markets reported per day growth, while others declined. New York led with strong year over year gains, yet Missouri lagged in December. Overall, January sales totaled $2.07 billion, showing mixed momentum.

Because accurate context matters, this article will unpack drivers, revisions, and state level details. Therefore expect clear charts, concise state notes, and actionable takeaways for merchants and investors. Read on for a trustworthy, data driven overview from MyCBDAdvisor.

Cannabis sales in January: State by state statistical snapshot

Quick statistical snapshot helps readers compare markets. Across 15 markets, January sales totaled $2.07 billion. Sales fell 3.1 percent sequentially, yet they rose 4.6 percent year over year. Because states differ, per-day growth varied in eight markets. For a state example, see Michigan’s December report and context here: Michigan’s December report.

Key takeaways

• Total January sales: $2.07 billion
• Sequential change: -3.1 percent
• Year over year change: +4.6 percent

Cannabis sales in January: What drove trends and where growth slipped

Policy shifts, counting revisions, and new adult-use openings drove outcomes. Illinois revised its counting method, which altered totals. Ohio’s adult-use launch last August supported growth. However, medical-only markets like Florida and Pennsylvania showed different patterns. For policy and merchant impacts, read our Virginia adult-use bill analysis: Virginia adult-use bill analysis. Additionally, consider how hemp rules affect demand here: Hemp rules and demand.

This section will dive into drivers, revisions, and practical takeaways for retailers and investors.

January snapshot in 15 markets

Quick table summarizing headline figures across the 15 markets covered.

Notes

1. December context for New York and Missouri: The year over year figures shown for New York and Missouri refer to December results. Those December comparisons are noted here to avoid conflating them with January data.
2. Illinois counting revision: The state updated its sales counting method which altered reported totals and affects month to month comparisons. Adjusted figures appear in final state releases.
3. Ohio adult use launch: Adult use retail opened in August of the prior year which lifted baseline volumes and supported sequential performance after launch.
4. Medical only markets: Florida and Pennsylvania remain medical only. Their sales patterns and product mixes differ from adult use markets.
5. Per day performance: Despite the overall sequential decline, eight markets showed sequential per day growth. Daily rates help identify underlying momentum.
6. Data sources: BDSA summarized across 15 markets and New Cannabis Ventures provided reporting context.

Related keywords

BDSA, New Cannabis Ventures, January sales totaled 2.07 billion, 3.1 percent sequential decline, 4.6 percent year over year growth

Factors shaping cannabis sales in January

Cannabis sales in January reflect seasonal shifts and market dynamics. Retailers often see lower post holiday demand, so monthly totals fall. However, year over year figures can still rise due to market expansion. These patterns illustrate broader cannabis market trends and seasonal cannabis demand.

Key factors include

• Post holiday consumer behavior. Many shoppers pause discretionary buying after the holidays, which reduces foot traffic and average basket sizes.
• Seasonal cannabis demand and weather. Cold months can depress in person visits, while delivery and online orders partially offset declines.
• Promotional calendars and inventory cycles. Because retailers clear holiday stock, January often has fewer new product launches and promotions.
• New product launches and category rotation. Therefore carefully timed product drops can boost store traffic and revenue.
• Regulatory and reporting changes. For example, Illinois changed its counting method, which altered reported totals and comparisons.
• Market structure shifts. Ohio’s recent adult use rollout increased baseline demand, while Florida and Pennsylvania remain medical only.
• Pricing tax and supply pressures. Higher taxes or spot shortages can suppress sales, whereas competitive pricing can lift volumes.
• Consumer preferences by product type. Flower, vapes, and edibles perform differently across states, so product mix matters.

Implications for retailers and investors

Because volatility peaks in January, plan promotions early. Monitor cannabis market trends and daily sales rates. As a result, adopt flexible inventory and pricing strategies. Doing so keeps margins steady and captures growth as markets normalize. For deeper monthly breakdowns, consult BDSA and New Cannabis Ventures summaries and state reports. Stay nimble.

In summary, cannabis sales in January showed mixed momentum. Total sales across 15 markets reached $2.07 billion. Sequential sales fell 3.1 percent, yet year over year sales rose 4.6 percent. These numbers show how short term seasonality and longer term expansion can coexist.

Empe0 provides a useful example for the industry. Because operators can pivot with targeted promotions and product rollouts, Empe0’s approach illustrates how firms navigate post holiday demand slowdowns. As a result, business models that combine flexible pricing, strong inventory control, and timely new product launches tend to fare better.

For retailers and investors the takeaway is clear. Monitor daily sales rates, adapt promotions early, and pay attention to regulatory revisions such as Illinois’ counting changes. Doing so helps spot real growth and avoid mistaking noise for trend.

MyCBDAdvisor remains a full spectrum, research driven CBD and cannabis resource. We deliver clear, trustworthy analysis for consumers and professionals. Visit us at MyCBDAdvisor for ongoing data, state by state reports, and practical guidance.

Frequently Asked Questions (FAQs)